Skip to main content

U.S. Department of Health and Human Services Designates Four Nutrients of Public Health Concern Validating Glucose Health, Inc. (OTC: GLUC) Patent Pending Soluble Fiber-Based Nutrition Formulation

Written by Customer Service on . Posted in Public Companies.

BENTONVILLE, Ark., June 30, 2025 (GLOBE NEWSWIRE) — Glucose Health, Inc. (OTC: GLUC), a publicly traded company specializing in diabetic nutrition and soluble fiber-based nutrition products, today commented on the U.S. Department of Health and Human Services (HHS) and U.S. Department of Agriculture (USDA) official recognition and designation of dietary fiber as a nutrient of public health concern in the Dietary Guidelines for Americans, 2020–20251.

Dietary fiber is one of four nutrients identified by HHS and USDA as critically under-consumed, to the detriment of the well-being of Americans. This federal designation of public health concern underscores a significant public health deficiency and is expected to drive increased government funding of dietary fiber awareness campaigns leading to follow-on demand for dietary fiber-based nutrition solutions. Among the companies best positioned to benefit from the designation issued by HHS and USDA is Glucose Health, Inc., which began scientific formulation and product development of its now patent pending soluble fiber-based nutrition products in 2017.

Glucose Health, Inc.’s flagship diabetic nutrition brand GlucoDown® is a dietary fiber-infused nutrition drink scientifically formulated to support balanced glucose levels particularly after meals. GlucoDown® competes in the diabetic nutrition category and is found on the shelves of national pharmacy chains alongside products such as Glucerna® (Abbott Laboratories, Abbott, ABT) and Boost® (Nestlé USA, Inc., Nestlé S.A., Nestlé, NSRGY). GlucoDown® offers health-conscious consumers a differentiated focus on providing dietary fiber’s established metabolic benefits via a refreshing beverage offered in powdered drink flavors and iced teas.

Glucose Health, Inc. also utilizes a variant of its patent pending formulation in its brand Fiber Up®, a delicious-tasting powdered beverage dietary fiber supplement targeting digestive and gut health. Scientifically formulated to compete with Metamucil® (The Procter & Gamble Company, P&G, PG), Fiber Up® builds upon the company’s mission to make fiber supplementation effective and enjoyable.

“The federal government’s recognition of dietary fiber as a nutrient of public health concern validates what has been our core mission since 2017” said Murray Fleming, CEO of Glucose Health, Inc. “We anticipated this public health priority and began development work formulating GlucoDown® and Fiber Up® to give consumers effective but still flavorful ways to contribute to their overall metabolic health. We believe Glucose Health, Inc. is uniquely positioned at the intersection of evolving public health priorities and anticipated rising consumer demand.”

1U.S. Department of Health and Human Services and U.S. Department of Agriculture. Dietary Guidelines for Americans, 2020–2025. 9th Edition. December 2020. Available at https://www.dietaryguidelines.gov

CONTACT: Investor Contact:
Investor Relations
info@glucosehealthinc.com
www.glucosehealthinc.com
OTC: GLUC

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.